Case Summary:

Gemini said

In the case of Damri v. LivePerson, Inc. (Docket No. 25-964), argued before the U.S. Court of Appeals for the Second Circuit on February 20, 2026, the relevant facts are as follows:

Fact Summary

The litigation is a federal securities class action brought on behalf of investors who purchased shares of LivePerson, Inc., a conversational AI company, between May 2022 and early 2024.

The core factual dispute involves the company’s February 2022 acquisition of WildHealth, a precision medicine startup, for approximately $150 million.

Plaintiffs allege that LivePerson and its executives made false and misleading statements regarding the financial health and growth prospects of WildHealth whil ...